Lineage Cell Therapeutics Inc May Offer And Sell Common Shares Of Up To $40M From Time To Time Through Or To B. Riley
Portfolio Pulse from Benzinga Newsdesk
Lineage Cell Therapeutics Inc (LCTX) has announced plans to potentially offer and sell common shares worth up to $40M through or to B. Riley, according to an SEC filing.
March 22, 2024 | 8:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Lineage Cell Therapeutics Inc may sell common shares up to $40M through B. Riley, as per an SEC filing.
The potential sale of up to $40M in common shares by LCTX through B. Riley could lead to stock dilution, which typically results in a decrease in the share price due to the increase in the number of shares outstanding without a corresponding increase in the company's value. This news is directly related to LCTX and is of high importance to investors as it affects the equity structure and could influence the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100